ALKS vs JAZZ: Side-by-Side Comparison
Compare Alkermes plc (ALKS) and Jazz Pharmaceuticals plc (JAZZ) side by side: market cap USD 9.10B vs USD 15.28B. Financials, growth and model signals on Bullrun.
| Metric | ALKS | JAZZ |
|---|---|---|
| Company | Alkermes plc | Jazz Pharmaceuticals plc |
| Country / Exchange | Ireland · NASDAQ | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Biotechnology |
| Market cap | USD 9.10B | USD 15.28B |
| P/E ratio | 60.7 | — |
| Dividend yield | — | — |
| Valuation model | 51.7% overvalued | — |
| Revenue (FY2025) | USD 1.48B | USD 4.27B |
| Revenue growth YoY | -5.2% | +4.9% |
| Net income | USD 241.70M | USD -356.15M |
| Gross margin | 86.7% | — |
| Diluted EPS | 1.43 | -5.84 |